These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 6189851)

  • 1. Estrogen receptors in human prostate: evidence for multiple binding sites.
    Ekman P; Barrack ER; Greene GL; Jensen EV; Walsh PC
    J Clin Endocrinol Metab; 1983 Jul; 57(1):166-76. PubMed ID: 6189851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Steroid receptor content in cytosol from normal and hyperplastic human prostates.
    Ekman P; Snochowski M; Dahlberg E; Bression D; Högberg B; Gustafsson JA
    J Clin Endocrinol Metab; 1979 Aug; 49(2):205-15. PubMed ID: 88456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Androgen- and estrogen-receptor content in spontaneous and experimentally induced canine prostatic hyperplasia.
    Trachtenberg J; Hicks LL; Walsh PC
    J Clin Invest; 1980 May; 65(5):1051-9. PubMed ID: 6154062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen receptors in the human prostate, seminal vesicle, epididymis, testis, and genital skin: a marker for estrogen-responsive tissues?
    Murphy JB; Emmott RC; Hicks LL; Walsh PC
    J Clin Endocrinol Metab; 1980 May; 50(5):938-48. PubMed ID: 7372780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective increase in type II estrogen-binding sites in the dysplastic dorsolateral prostates of noble rats.
    Ho SM; Yu M
    Cancer Res; 1993 Feb; 53(3):528-32. PubMed ID: 7678774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrone receptor formation during the processing of estradiol-receptor complex in MCF-7 cells.
    Hansen ER; Brooks SC
    Cancer Res; 1982 May; 42(5):1967-74. PubMed ID: 7066908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Androgen-binding proteins in human benign prostatic hypertrophy.
    Rosen V; Jung I; Baulieu EE; Robel P
    J Clin Endocrinol Metab; 1975 Oct; 41(4):761-70. PubMed ID: 51854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of estradiol on estrogen receptor, progesterone receptor, and tyrosinase in hamster melanoma transplanted into athymic mice.
    Hitselberger MH; Schleicher RL; Beattie CW
    Cancer Res; 1988 Jul; 48(13):3720-7. PubMed ID: 3132319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterogeneity of [3H]estradiol binding sites in the rat prostate: properties and distribution of type I and type II sites.
    Yu M; Cates J; Leav I; Ho SM
    J Steroid Biochem; 1989 Sep; 33(3):449-57. PubMed ID: 2779236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrophilin immunoreactivity versus estrogen receptor binding activity in meningiomas: evidence for multiple estrogen binding sites.
    Lesch KP; Schott W; Gross S
    Surg Neurol; 1987 Sep; 28(3):181-8. PubMed ID: 3306997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitation of cytosolic and nuclear estrogen and progesterone receptor in benign, untreated, and treated malignant human prostatic tissue by radioligand binding and enzyme-immunoassays.
    Mobbs BG; Johnson IE; Liu Y
    Prostate; 1990; 16(3):235-44. PubMed ID: 1691841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterogeneity of nuclear estrogen-binding sites in the rat uterus: a simple method for the quantitation of type I and type II sites by [3H]estradiol exchange.
    Markaverich BM; Williams M; Upchurch S; Clark JH
    Endocrinology; 1981 Jul; 109(1):62-9. PubMed ID: 7238414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha-1 adrenoceptors in human prostate: characterization and alteration in benign prostatic hypertrophy.
    Yamada S; Ashizawa N; Ushijima H; Nakayama K; Hayashi E; Honda K
    J Pharmacol Exp Ther; 1987 Jul; 242(1):326-30. PubMed ID: 2441028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of estrogen and progestin receptor concentrations in an experimental rat prostatic carcinoma by estrogen, antiestrogen, and progesterone.
    Mobbs BG; Johnson IE; DeSombre ER; Toth J; Hughes A
    Cancer Res; 1987 May; 47(10):2645-51. PubMed ID: 3552202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of the low affinity high capacity estrogenic binding in human benign prostatic hypertrophy.
    Nijs M; Brassinne C; Coune A
    Cancer Biochem Biophys; 1993 Jun; 13(3):195-208. PubMed ID: 7509256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Androgen receptor in rat skeletal muscle: characterization and physiological variations.
    Michel G; Baulieu EE
    Endocrinology; 1980 Dec; 107(6):2088-98. PubMed ID: 6968675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Demonstration of a progestin receptor in human benign prostatic hyperplasia and prostatic carcinoma.
    Gustafsson JA; Ekman P; Pousette A; Snochowski M; Högberg B
    Invest Urol; 1978 Mar; 15(5):361-6. PubMed ID: 76618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subcellular distribution of androgen receptors in human normal, benign hyperplastic, and malignant prostatic tissues: characterization of nuclear salt-resistant receptors.
    Barrack ER; Bujnovszky P; Walsh PC
    Cancer Res; 1983 Mar; 43(3):1107-16. PubMed ID: 6186370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization and measurement of cytoplasmic and nuclear oestradiol-17 beta-receptor proteins in benign hypertrophied human prostate.
    Auf G; Ghanadian R
    J Endocrinol; 1982 Jun; 93(3):305-17. PubMed ID: 6177813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Properties of the estrogen receptor in the human oviduct and its interaction with ethinylestradiol and mestranol in vitro.
    Muechler EK; Kohler D
    J Clin Endocrinol Metab; 1980 Nov; 51(5):962-7. PubMed ID: 7419693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.